Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is D  [Clear All Filters]
2024
Kerr CM, Silver SE, Choi YSun, Floy ME, Bradshaw AD, Cho S-W, Palecek SP, Mei Y. Decellularized heart extracellular matrix alleviates activation of hiPSC-derived cardiac fibroblasts. Bioact Mater. 2024;31:463-474.
Schofield RC, Scordo M, Shah G, Carlow DC. Determination of Busulfan and Melphalan in Plasma by Turbulent Flow Chromatography-Tandem Mass Spectrometry. Methods Mol Biol. 2024;2737:141-151.
Hutcherson SM, Schofield RC, Carlow DC. Determination of Treosulfan and Fludarabine in Plasma by Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry (TFLC-MS/MS). Methods Mol Biol. 2024;2737:453-463.
Wang Y, Han Y, Xu D-X. Developmental impacts and toxicological hallmarks of silver nanoparticles across diverse biological models. Environ Sci Ecotechnol. 2024;19:100325.
Zhang S, Zhao M, Li S, Yang R, Yin N, Faiola F. Developmental toxicity assessment of neonicotinoids and organophosphate esters with a human embryonic stem cell- and metabolism-based fast-screening model. J Environ Sci (China). 2024;137:370-381.
Wang X, Chen Q, Lackford B, Hu G. Dissecting the Role of the Ccr4-Not Deadenylase Complex in Pluripotency and Differentiation. Methods Mol Biol. 2024;2723:125-141.
Ajmeera D, Ajumeera R. Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance. Genes Dis. 2024;11(1):148-175.
Mukhtar T, Taylor V. Dynamic transcriptional programs define distinct mammalian cortical lineages. Neural Regen Res. 2024;19(2):387-389.
2023
Liu Y, Wang M, Guo Y, Wang L, Guo W. D-2-hydroxyglutarate dehydrogenase governs adult neural stem cell activation and promotes histone acetylation via ATP-citrate lyase. Cell Rep. 2023;42(2):112067.
Zhang L, Zhang S, Fan Z, Jiang Z, Li S, Liu A, Sun J. [D816V mutation of KIT specifically induces phosphorylation of HNRNPL and HNRNPK in COS-1 cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023;39(2):138-143.
Zhang X, Wang Q, Zhang R, Kong Z. DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation. Int J Radiat Biol. 2023:1-17.
Lu Y, Tang K, Wang S, Tian Z, Fan Y, Li B, Wang M, Zhao J, Xie J. Dach1 Deficiency Drives Alveolar Epithelium Apoptosis in Pulmonary Fibrosis via Modulating C-Jun/Bim Activity. Transl Res. 2023.
Graham F. Daily briefing: A third person is HIV-free after stem-cell transplant. Nature. 2023.
Arce-Gorvel V, Hysenaj L, de Laval B, Sieweke MH, Sarrazin S, Gorvel J-P. [The dance between Brucella and hematopoietic stem cells]. Med Sci (Paris). 2023;39(11):822-824.
Epifanova E, Nguyen L. The dangers of rubella virus. Elife. 2023;12.
Kooiker KB, Mohran S, Turner KL, Ma W, Martinson A, Flint G, Qi L, Gao C, Zheng Y, McMillen TS, et al. Danicamtiv Increases Myosin Recruitment and Alters Cross-Bridge Cycling in Cardiac Muscle. Circ Res. 2023.
Zou J, Sarti JEduardo Ri, Strasfeld L. Daptomycin-associated pulmonary toxicity sans eosinophilia in a hematopoietic cell transplant recipient with profound leukopenia. Transpl Infect Dis. 2023:e14029.
Begna KH, Abdallah NH, Janania-Martinez M, Mangaonkar AA, Rangan A, Herrick JL, Gangat N. Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant. Haematologica. 2023.
McMillan A, Basu S, Karunanithi K, Parkins E, Lau EYan Ming, Cook G, Parrish C, Al-Kaisi F, Pratt G, Shafeek S, et al. Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis. Br J Haematol. 2023.
Kaiser MF, Hall A, Walker K, Sherborne A, de Tute RM, Newnham N, Roberts S, Ingleson E, Bowles K, Garg M, et al. Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma. J Clin Oncol. 2023:JCO2202567.
Lockhart A, Easterbrook J, Wilson L, Laird J, Campbell V. Daratumumab interference with blood-compatibility testing after autologous stem cell transplantation. Transfus Med. 2023.
Hashmi H, Shebli A, Jain J, Khasawneh G, Mohan M, Mahmoudjafari Z, Cui W, McGuirk J, Shune L, Ahmed N, et al. Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple Myeloma. Transplant Cell Ther. 2023.
Liu X-S, Yuan L-L, Gao Y, Ming X, Zhang Y-H, Zhang Y, Liu Z-Y, Yang Y, Pei Z-J. DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma. J Transl Med. 2023;21(1):574.
Sarno J, Domizi P, Liu Y, Merchant M, Pedersen CBligaard, Jedoui D, Jager A, Nolan GP, Gaipa G, Bendall SC, et al. Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia. Nat Commun. 2023;14(1):2935.
Jia L, Zhang Y, Sun S, Hao X, Wen Y. Dasatinib regulates the proliferation and osteogenic differentiation of PDLSCs through Erk and EID3 signals. Int J Med Sci. 2023;20(11):1460-1468.

Pages